Get the Stockscreener App
14.47
0.72%
-0.105
Pre-market:
14.74
0.265
+1.83%
Fortrea Holdings Inc stock is traded at $14.47, with a volume of 1.70M.
It is down -0.72% in the last 24 hours and up +49.23% over the past month.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
See More
Previous Close:
$14.58
Open:
$14.25
24h Volume:
1.70M
Relative Volume:
1.27
Market Cap:
$1.34B
Revenue:
$2.98B
Net Income/Loss:
$-300.00M
P/E Ratio:
-4.2574
EPS:
-3.4
Net Cash Flow:
$225.00M
1W Performance:
+14.61%
1M Performance:
+49.23%
6M Performance:
+176.77%
1Y Performance:
-39.00%
1-Day Range:
$13.06
$14.52
1-Week Range:
$12.12
$15.05
52-Week Range:
$3.97
$23.97
Fortrea Holdings Inc Stock (FTRE) Company Profile
Name
Fortrea Holdings Inc
Sector
Industry
Phone
877-495-0816
Address
8 MOORE DRIVE, DURHAM
Compare FTRE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FTRE
Fortrea Holdings Inc
|
14.47 | 1.35B | 2.98B | -300.00M | 225.00M | -3.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-02-25 | Initiated | Truist | Hold |
| Apr-10-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-06-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-08-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-24-24 | Resumed | Barclays | Equal Weight |
| Jun-06-24 | Initiated | Goldman | Neutral |
| May-29-24 | Initiated | TD Cowen | Hold |
| May-28-24 | Initiated | Mizuho | Neutral |
| Mar-22-24 | Initiated | Robert W. Baird | Neutral |
| Mar-06-24 | Initiated | Deutsche Bank | Hold |
| Jan-05-24 | Initiated | William Blair | Mkt Perform |
| Jan-04-24 | Initiated | Jefferies | Buy |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Dec-01-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-14-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-19-23 | Initiated | Citigroup | Neutral |
| Sep-14-23 | Initiated | Evercore ISI | In-line |
| Aug-16-23 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Initiated | BofA Securities | Underperform |
View All
Fortrea Holdings Inc Stock (FTRE) Latest News
Fortrea Holdings Inc. (NASDAQ:FTRE) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
What dividend safety score for Fortrea Holdings Inc. stockJuly 2025 Trade Ideas & Stock Timing and Entry Methods - Newser
Will Fortrea Holdings Inc. (K67) stock outperform global peersJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - Newser
Fortrea (NASDAQ:FTRE) Shares Up 10.1%Time to Buy? - MarketBeat
Fortrea, SCTbio announce strategic collaboration agreement - TipRanks
SCTbio and Fortrea forge strategic collaboration to accelerate cell and gene therapy development and delivery - MarketScreener
Fortrea, SCTbio Collaborate Over Cell, Gene Therapy Development, Delivery - marketscreener.com
Fortrea (FTRE) and SCTbio team up to speed cell and gene therapy development - Stock Titan
Geode Capital Management LLC Increases Stake in Fortrea Holdings Inc. $FTRE - MarketBeat
Fortrea (FTRE) Valuation Check After Investigation into Alleged Overstated Revenue, Cost Savings, and 2025 EBITDA Targets - Yahoo Finance
Improved Revenues Required Before Fortrea Holdings Inc. (NASDAQ:FTRE) Stock's 26% Jump Looks Justified - 富途牛牛
How Fortrea Holdings Inc. (K67) stock compares with market leaders2025 Big Picture & Weekly High Return Opportunities - Newser
Brandes Investment Partners LP Acquires 94,448 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat
Is Fortrea Holdings Inc. stock trading at a premium valuationJuly 2025 Gainers & Weekly Return Optimization Alerts - Newser
Fortrea (FTRE) Valuation Check as Legal Probe Questions Revenue Recognition and 2025 EBITDA Targets - simplywall.st
Levi & Korsinsky Notifies Fortrea Holdings Inc. (FTRE) Investors - The National Law Review
Why (FTRE) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Transcript : Fortrea Holdings Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 01 - marketscreener.com
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Will Fortrea Holdings Inc. (K67) stock benefit from sector leadership2025 Big Picture & Low Risk Entry Point Tips - Newser
SG Americas Securities LLC Reduces Position in Fortrea Holdings Inc. $FTRE - MarketBeat
How strong is Fortrea Holdings Inc. stock revenue growthTrade Exit Summary & Real-Time Buy Zone Alerts - Newser
Important Notice to Long-Term Shareholders of Cytokinetics, - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdi - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Stockholders to Connect - ACCESS Newswire
Is Fortrea Holdings Inc. stock a safe haven assetCEO Change & Detailed Earnings Play Strategies - BỘ NỘI VỤ
Envestnet Asset Management Inc. Sells 69,467 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat
Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Can Fortrea Holdings Inc. stock maintain growth trajectory2025 Fundamental Recap & AI Enhanced Trading Signals - BỘ NỘI VỤ
Fortrea (NASDAQ:FTRE) Stock Price Up 7.4%What's Next? - MarketBeat
ProShare Advisors LLC Makes New $117,000 Investment in Fortrea Holdings Inc. $FTRE - MarketBeat
Does Fortrea’s (FTRE) Debt Buyback Mark a Shift in Its Post-Divestiture Financial Strategy? - Yahoo Finance
Fortrea Holdings (NASDAQ:FTRE) Nasdaq Futures Mirror Biotech Shifts - Kalkine Media
Fortrea completes $75.7M senior notes tender offer - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Fortrea Stock Gains on Debt RepurchaseFinancial Update 2025News and Statistics - IndexBox
Fortrea (FTRE) Stock Trades Up, Here Is Why - TradingView
Fortrea (Nasdaq: FTRE) to Join Citi and Evercore Healthcare Investor Conferences - Stock Titan
Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences - Yahoo Finance
BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know - Barchart.com
FTRE Form 4 shows director award of 20,916 restricted stock units - Stock Titan
Fortrea completes debt tender offer, reducing outstanding notes By Investing.com - Investing.com Nigeria
Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand - MarketScreener
Attention Long-Term Shareholders of Fortrea Holdings, Inc. (NASDAQ: FTRE); enCore Energy Corp. (NASDAQ: EU); Humana Inc. (NYSE: HUM); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire
Fortrea Completes Repurchase of $75.7 Million of Senior Notes - MarketScreener
Fortrea completes $75.7 million senior notes tender offer utilizing cash on hand - MarketScreener
Fortrea completes debt tender offer, reducing outstanding notes - Investing.com
Fortrea (Nasdaq: FTRE) repurchases $75.7M notes, trimming outstanding issue to $494.3M - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings, Inc. (FTRE) Investors to Inquire about Securities Investigation - ACCESS Newswire
NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know - Yahoo Finance
Understanding Momentum Shifts in (FTRE) - news.stocktradersdaily.com
Fortrea Holdings Inc Stock (FTRE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):